NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Megaloblastic Anemia
    Megaloblastic Anemia
    medium
    microscope Pathology

    A 42-year-old woman with a 10-year history of rheumatoid arthritis on long-term methotrexate therapy presents with macrocytic anemia and hypersegmented neutrophils. Serum B12 and folate levels are both low. Which is the most common cause of megaloblastic anemia in this patient?

    A. Methotrexate-induced folate deficiency
    B. Concurrent pernicious anemia
    C. Dietary folate insufficiency
    D. Nitrous oxide inhalation

    Explanation

    Methotrexate-Induced Megaloblastic Anemia

    Key Point
    In patients on long-term methotrexate therapy, methotrexate-induced folate deficiency is the most common cause of megaloblastic anemia. Methotrexate inhibits dihydrofolate reductase, blocking the conversion of dihydrofolate to tetrahydrofolate, which is essential for DNA synthesis.
    High-YieldNEET PG
    Methotrexate is a folate antagonist used in:
    • Rheumatoid arthritis (RA)
    • Psoriasis
    • Inflammatory bowel disease
    • Hematologic malignancies
    • Autoimmune conditions

    Megaloblastic anemia is a well-recognized toxicity of long-term methotrexate use.

    Mechanism of Methotrexate-Induced Megaloblastic Anemia

    Loading diagram...

    Comparison: Methotrexate vs. Other Causes in This Context

    Table
    CauseMechanismClinical ContextReversibility
    Methotrexate-induced folate deficiencyInhibits dihydrofolate reductaseLong-term MTX therapy (RA, psoriasis)Reversible with folinic acid (leucovorin)
    Pernicious anemiaAutoimmune gastritis; anti-IF antibodiesAutoimmune disease (can coexist with RA)Irreversible; requires B12 supplementation
    Dietary folate deficiencyInadequate intakeMalnutrition, alcoholismReversible with dietary supplementation
    Nitrous oxide inhalationInactivates B12 cofactorSubstance abuseReversible if caught early
    Clinical Pearl
    Methotrexate-induced megaloblastic anemia is preventable and reversible with folinic acid (leucovorin) supplementation. Patients on long-term methotrexate should receive concurrent folinic acid to prevent folate deficiency.

    Mnemonic: MTX TOXICITY — Methotrexate → Teratogenic, Oral ulcers, Xerostomia, Immunosuppression, Cirrhosis, Infection, Thrombocytopenia, Yeast overgrowth (plus megaloblastic anemia)

    Why Methotrexate Is the Most Common Cause in This Patient

    1. 1.
      Clear temporal relationship: Patient has been on methotrexate for 10 years
    2. 2.
      Mechanism is direct: Methotrexate directly inhibits folate metabolism
    3. 3.
      Both B12 and folate are low: This pattern is consistent with methotrexate-induced folate deficiency (B12 may be secondarily low due to impaired absorption from intestinal damage)
    4. 4.
      Reversibility: Folinic acid supplementation will correct the anemia, confirming methotrexate as the cause
    Warning
    Do not confuse methotrexate-induced folate deficiency with pernicious anemia. While both can coexist in RA patients (RA is an autoimmune disease), the primary cause here is methotrexate toxicity given the 10-year history of therapy.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →